Vantage logo

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.